Blood cancer treatment and diagnostics market
Global Blood cancer treatment and diagnostics market, By Cancer type (Leukemia, Non-Hodgkin lymphoma, Hodgkin lymphoma, Multiple myeloma, Myelodysplastic syndromes (MDS), Myeloproliferative neoplasms (MPNs), Waldenstrom macroglobulinemia), By Diagnosis (Blood tests, Biopsies, Imaging tests), By Treatment (Medications, Chemotherapy Drugs, Monoclonal antibodies, Immunotherapy, Radiation Therapy, Stem Cell Therapy, Others), By product type (Kits, Vaccines, Medication), Based On Region, And Segment Forecasts, 2024 – 2030
- Product Id: BMRC 3059
- Pages: 300
- Publish Date: Oct-2024
- Category: Pharmaceutical
Fill Details
Verify Email
Check your inbox for Sample + Methodology
Note: For delivery of sample pages you must have a Domain Specific EmailID, normally your business email address complies. Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSNetc are not accepted
Segments
Global Blood cancer treatment and diagnostics market Segmentation: -
-
By Cancer type:
- Leukemia
- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Multiple myeloma
- Myelodysplastic syndromes (MDS)
- Myeloproliferative neoplasms (MPNs)
- Waldenstrom macroglobulinemia
-
By Diagnosis:
- Blood tests
- o Complete blood count test
- o Circulating tumor cell test
- o Blood Protein Testing
- o Others
- Biopsies
- Imaging tests
- Computed tomography (CT) scan
- Magnetic resonance imaging (MRI)
- Positron emission tomography (PET) scan
- X-ray
- Ultrasound
- Others
-
By Treatment:
- Blood tests
- Medications
- Proteasome Inhibitors
- Bortezomib
- Ixazomib
- Carfilzomib
- Histone Deacetylase (HDAC) Inhibitors
- Others
- Chemotherapy Drugs
- Bendamustine
- Etoposide
- Doxorubicin
- Liposomal Doxorubicin
- Cyclophosphamide
- Melphalan
- Vincristine
- Others
- Monoclonal antibodies
- Daratumumab
- Isatuximab
- Elotuzumab
- Others
- Immunotherapy:
- Lenalidomide
- Thalidomide
- Pomalidomide
- Corticosteroids
- Dexamethasone
- Prednisone
- Others
- Radiation Therapy
- Stem Cell Therapy
- Others
-
By product type:
- Kits
- Vaccines
- Medication
Regions and Country
North America
- U.S.
- Canada
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Sweden
- Netherlands
- Turkey
- Switzerland
- Belgium
- Rest of Europe
Asia-Pacific
- South Korea
- Japan
- China
- India
- Australia
- Philippines
- Singapore
- Malaysia
- Thailand
- Indonesia
- Rest of APAC
Latin America
- Mexico
- Colombia
- Brazil
- Argentina
- Peru
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of MEA
Key Players
Key Players of Global Blood Cancer Treatment & Diagnostic Market Report-
- Hoffmann-La Roche Ltd.
- Mylan N.V
- Teva Pharmaceutical Industries Ltd
- Sanofi
- Pfizer Inc.
- GlaxoSmithKline plc
- Novartis AG
- Bayer AG
- Eli Lilly and Company
- Merck & Co., Inc.
- Allergan
- AstraZeneca
- Johnson & Johnson Private Limited
- Cipla Inc.
- Abbott
- AbbVie Inc.
- Merck KGaA
- LEO Pharma A/S
- Bausch Health Companies Inc.
- Sun Pharmaceutical Industries Ltd.
- Aurobindo Pharma
- Lupin
- Hikma Pharmaceuticals PLC
- Fresenius Kabi AG
- Amneal Pharmaceuticals LLC
+44-1173181773
sales@brandessenceresearch.com
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination interested? please email us hr@brandessenceresearch.com
JOIN USFIND ASSISTANCE
LONDON OFFICE
BrandEssence® Market Research and Consulting Pvt ltd.
124, City Road, London EC1V 2NX
FOLLOW US
© Copyright 2024-25 BrandEssence® Market Research and Consulting Pvt ltd. All Rights Reserved | Designed by BrandEssence®
